Clinical trial

Evaluation of GM101 Injection in Patients With Parkinson's Disease

NCT07100171

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-05-29

PhaseEARLY_PHASE1

Study timeline

Study start (actual)2025-05-29Date precision: day

Registry last updated2025-08-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Parkinson's Diseaseunresolved

Interventions

Biological: GM101OTHER

Sponsors & collaborators

Genemagic Biosciences Co., Ltdlead sponsor

Mapped research locations

ChangshaChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07100171 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.